LONDON, UK/ Paris, France – 23 June 2022: Funds advised by BC Partners, a leading international investment firm, announced today that they have entered into exclusive discussions to acquire a majority stake in Havea, the French leader in natural healthcare serving the European market, from 3i Group. Terms of the transaction were not disclosed.
This new partnership would support Havea’s best-in-class management team to execute its strategy of strong organic growth, empower it to accelerate its pace of M&A with complementary businesses, and continue investing in digitalisation.
Havea is a leading French natural healthcare group with a major presence across Europe: The Company’s five key Strategic Brands hold market-leading positions in their respective categories. The business has a history of consistently delivering above-market organic growth as a result of a focused strategy tailored to each brand, with strong underlying cash flow generation. It currently employs over 800 people, and is headquartered in Boufféré, France.
Mark Hersee, Partner at BC Partners, said: “Havea benefits from long-term structural tailwinds, and embodies the key themes that we look for in a healthcare business, particularly in pharma, of providing strong value to patients and healthcare payors alike, preventative care, and digitalisation. Havea has an outstanding track record of delivery, true market leadership, and a best-in-class management team, which are key criteria we seek in our investments. We look forward to working with the management team in realising the full potential of the Group.”
Fouad Jaïdi, Managing Director at BC Partners, said: “Consistent with our owner operator mindset we are excited to help Nicolas Brodetsky, CEO of Havea, and his team execute on their strategy and support them in pursuing value accretive transactions. The business has made five key strategic acquisitions since 2017, and we look forward to working with the team to drive Havea’s continued international expansion. We will use our expertise to support the company’s continued focus on meeting customer needs via increased investment in digitalisation.”
Nicolas Brodetsky, CEO, Havea, said: “We welcome this opportunity to partner with BC Partners, which has extensive experience in fostering portfolio companies’ potential and will support us in this next and exciting stage of our growth, with a continued focus on improving our consumers quality of life with natural products. We share a common vision of the winning strategy to accelerate our development on a larger scale and become the undisputed European leader. We thank 3i for their active support, which has helped Havea grow and establish its leadership position in natural healthcare.”
David Morin, Managing Director and Head of Europe, Private Equity at PSP Investments, said: “Over the last years, Nicolas Brodetsky, CEO of Havea, and his talented team have built great brands and have positioned Havea to benefit from industry tailwinds. We are excited to team up with BC Partners, who have been one of PSP Investments’ core partners for many years. Together, we will provide the long-term strategic capital to support Havea in achieving its full potential through its next phase of development as a European leader in natural healthcare.”
Notes to Editors
About BC Partners
BC Partners is a leading investment firm with over €40 billion in assets under management across private equity, private debt, and real estate strategies. Established in 1986, BC Partners has played an active role for over three decades in developing the European buy-out market. Today BC Partners integrated transatlantic investment teams working from offices in Europe and North America and aligned across our four core sectors: Healthcare, TMT, Business Services & Industrials, and Consumer. Since its foundation, BC Partners has completed over 120 private equity investments in companies with a total enterprise value of over €160 billion and is currently investing its eleventh private equity buyout fund.
For further information, please visit https://www.bcpartners.com/
About PSP Investments
The Public Sector Pension Investment Board (PSP Investments) is one of Canada’s largest pension investment managers with C$230.5 billion of net assets under management as of March 31, 2022. It manages a diversified global portfolio composed of investments in public financial markets, private equity, real estate, infrastructure, natural resources and credit investments. Established in 1999, PSP Investments manages and invests amounts transferred to it by the Government of Canada for the pension plans of the federal Public Service, the Canadian Forces, the Royal Canadian Mounted Police and the Reserve Force. Headquartered in Ottawa, PSP Investments has its principal business office in Montréal and offices in New York, London and Hong Kong.
About Havea Group
Created in 1975 and headquartered in France (Boufféré / Paris), Havea is a leading European natural healthcare player dedicated to quality of life enhancement by empowering consumers to take care of their health using natural and organic products. Through its 5 Strategic Brands (Aragan, Biolane, Densmore, Dermovitamina and Vitavea), Havea designs, manufactures and distributes a wide range of products from functional and natural food supplements, to natural baby premium healthcare products. In 2021, Havea employed 800 staff and generated € 212m sales.